IPNEX

Licensable university IP

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins is marketed for licensing by University of California. It is documented in US patent US 9,572,873. The current assignee of record is University of California San Diego UCSD. Google Patents reports its legal status as “Active” (an automated indicator, not a legal determination). Its expected expiration is 2029-09-28.

Patent picture

FieldValueReliabilitySource
US patentUS 9,572,87395%HighGoogle Patents
Patent titleMethod of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins90%HighGoogle Patents
Current assigneeUniversity of California San Diego UCSD80%GoodGoogle Patents
Original assigneeUniversity of California San Diego UCSD85%GoodGoogle Patents
Legal statusActive70%ModerateGoogle Patents
Filing date2015-07-0790%HighGoogle Patents
Priority date2008-09-3090%HighGoogle Patents
Publication date2017-02-2190%HighGoogle Patents
Expected expiration2029-09-2875%ModerateGoogle Patents
Reliability of each field, at a glance:
  • High 90% and up
  • Good 80 to 89%
  • Moderate 70 to 79%
Hover a bar for the exact figure; the Source column links the citation.

Legal status is Google Patents' automated indicator, not a legal determination.

Joined to US 9,572,873 by its printed patent number (a deterministic match), then enriched from public Google Patents data. Fields are shown only where resolved against a public source; unresolved fields are omitted, never guessed.

Grouped under Biotechnology & Life Sciences · Materials & Chemistry, derived from its patent classification (CPC A61K, C07H, C07K, C12N; Google Patents).

Original listing

This technology is marketed for licensing by University of California. View the original listing.